Jan 12, 2022 / 01:15PM GMT
Tycho W. Peterson - JPMorgan Chase & Co, Research Division - Senior Analyst
All right. Good morning, everybody. Welcome to Day 3 of the Healthcare Conference. I'm Tycho Peterson [from the health and] science team. It's my pleasure to introduce our next company this morning, Bio-Techne. Just a very quick reminder, there's a submit question function on the website, if people have questions they want answered. And with that, let me turn it over to Chuck.
Charles R. Kummeth - Bio-Techne Corporation - CEO, President & Director
Thanks, Tycho. Well, welcome, everybody. It's Bio-Techne presentation. I'm happy to be here. I think this is [eighth] invite I've had. The first one was to a near closet size room with 7 people way up in the hotel, and I hope there are hundreds of you out there this year. But if not, we're going to pretend there is. And we have a great story to tell you, and we'll get going.
First, safe harbor, of course, and we will have forward-looking statements. And like always, you want to reconcile the non-GAAP to the GAAP, get online on
Bio-Techne Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers